Zobrazeno 1 - 10
of 301
pro vyhledávání: '"R., Neuwirtová"'
Publikováno v:
Mitochondrion. 4:321-329
It was hypothesised that mitochondrial iron overload in patients with refractory anemia with ring sideroblasts (RARS) results from mitochondrial DNA (mtDNA) mutations. To analyse the mtDNA sequence of iron storing mitochondria sensitively, we develop
Publikováno v:
Vnitrni lekarstvi. 59(7)
Publikováno v:
Casopis lekaru ceskych. 147(12)
The prognosis of multiple myeloma (MM) has substantially improved during last decades due to new, so-called targeted drugs--proteasome inhibitor bortezomib and immunomodulatory drugs (ImiDs), thalidomide and lenalidomide. They could be used in variou
Publikováno v:
Vnitrni lekarstvi. 53(2)
Publikováno v:
Casopis lekaru ceskych. 145(8)
Successful therapy with ATG and cyclosporine A in some myelodysplastic syndrome (MDS) patients led us to study the existence of T cells attacking autologous hemopoietic cells. In our study, we attempted to give the direct prove of autoreactive T cell
Autor:
O, Fuchs, R, Neuwirtová
Publikováno v:
Vnitrni lekarstvi. 52(6)
Posttranslational protein modifications are effective devices that cells use to control the functions of proteins. Ubiquitin-like protein modifiers (Ubls) are posttranslationally attached to proteins by enzymatic reactions that are similar to ubiquit
Autor:
O, Fuchs, R, Neuwirtová
Publikováno v:
Vnitrni lekarstvi. 52(4)
Proteasome is protein complex with proteolytic activity. Proteasomes are in addition to lysosomes the main proteolytic machinery of the eukaryotic cell. Proteins destined for degradation in proteasomes are marked by ubiquitinylation, which consists i
Publikováno v:
Casopis lekaru ceskych. 140(24)
Single cell gel electrophoresis or comet assay is used at present in the world to study of DNA damage, DNA repair and apoptosis. The aim of the work is to introduce the principle of comet assay to the medical community and to give a basic survey of i
Publikováno v:
Sbornik lekarsky. 103(3)
A number of prognostic scoring systems for patients with myelodysplastic syndrome (MDS) have been introduced since FAB classification of the MDS in 1982. Recently, the International Prognostic Scoring System (IPSS), published in 1997 by Greenberg et
Publikováno v:
Sbornik lekarsky. 103(3)
Myelodysplastic syndromes (MDS) are classified as oncohematologic, clonal diseases. However, some MDS subtypes lack malignant clinical features. Literary data on the clonality of blood cells in MDS are controversial. Therefore we examined the clonali